Cargando…

Prevention of SHIV transmission by topical IFN-β treatment

Understanding vaginal and rectal HIV transmission and protective cellular and molecular mechanisms is critical for designing new prevention strategies, including those required for an effective vaccine. The determinants of protection against HIV infection are, however, poorly understood. Increasing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Veazey, Ronald S., Pilch Cooper, Heather A., Hope, Thomas J., Alter, Galit, Carias, Ann M., Sips, Magdalena, Wang, Xiaolei, Rodriguez, Benigno, Sieg, Scott F., Reich, Adrian, Wilkinson, Peter, Cameron, Mark J., Lederman, Michael M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972705/ https://www.ncbi.nlm.nih.gov/pubmed/26838048 http://dx.doi.org/10.1038/mi.2015.146

Ejemplares similares

Topical application of entry inhibitors as "virustats" to prevent sexual transmission of HIV infection
por: Lederman, Michael M, et al.
Publicado: (2008)

Interferon-α Is the Primary Plasma Type-I IFN in HIV-1 Infection and Correlates with Immune Activation and Disease Markers
por: Hardy, Gareth A. D., et al.
Publicado: (2013)

Efficacy of topical tenofovir against transmission of a tenofovir-resistant SHIV in macaques
por: Dobard, Charles W, et al.
Publicado: (2015)

Modeling virus exposure during male to female transmission of HIV-1
por: Carias, A, et al.
Publicado: (2012)

Immune Responses and Viral Persistence in Simian/Human Immunodeficiency Virus SHIV.C.CH848-Infected Rhesus Macaques
por: Ziani, Widade, et al.
Publicado: (2021)

Transmitted/founder SHIV.D replicates in the brain, causes neuropathogenesis, and persists on combination antiretroviral therapy in rhesus macaques
por: Podgorski, Rachel M., et al.
Publicado: (2023)

Antibody and TLR7 Agonist Delay Viral Rebound in SHIV-Infected Monkeys
por: Borducchi, Erica N., et al.
Publicado: (2018)

OA011-02. Defining the mechanisms of HIV entry and interactions with the female genital tract
por: Carias, AM, et al.
Publicado: (2009)

SHIV-162P3 Infection of Rhesus Macaques Given Maraviroc Gel Vaginally Does Not Involve Resistant Viruses
por: Tsibris, Athe M. N., et al.
Publicado: (2011)

Persistence of viral RNA in lymph nodes in ART-suppressed SIV/SHIV-infected Rhesus Macaques
por: Cadena, Anthony M., et al.
Publicado: (2021)

Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus
por: Lagenaur, Laurel A, et al.
Publicado: (2011)

Prevention of Rectal SHIV Transmission in Macaques by Daily or Intermittent Prophylaxis with Emtricitabine and Tenofovir
por: García-Lerma, J. Gerardo, et al.
Publicado: (2008)

Prevention of Vaginal SHIV Transmission in Macaques by a Coitally-Dependent Truvada Regimen
por: Radzio, Jessica, et al.
Publicado: (2012)

Shiv Nadar School students visit CERN
por: Poulaillon, Jimmy, et al.
Publicado: (2023)

Oral Vaccination Approaches for Anti-SHIV Immunity
por: Velarde de la Cruz, Erandi, et al.
Publicado: (2021)

Toll-Like Receptor Ligands Induce Human T Cell Activation and Death, a Model for HIV Pathogenesis
por: Funderburg, Nicholas, et al.
Publicado: (2008)

Topical Delivery of Tenofovir Disoproxil Fumarate and Emtricitabine from Pod-Intravaginal Rings Protects Macaques from Multiple SHIV Exposures
por: Srinivasan, Priya, et al.
Publicado: (2016)

Th17 Cells Coordinate with Th22 Cells in Maintaining Homeostasis of Intestinal Tissues and both are Depleted in SIV-Infected Macaques
por: Xu, Huanbin, et al.
Publicado: (2014)

Influence of gut microbiome on mucosal immune activation and SHIV viral transmission in naive macaques
por: Sui, Yongjun, et al.
Publicado: (2018)

Antibody-based CCR5 blockade protects Macaques from mucosal SHIV transmission
por: Chang, Xiao L., et al.
Publicado: (2021)

Simian-Human Immunodeficiency Virus SHIV.C.CH505 Persistence in ART-Suppressed Infant Macaques Is Characterized by Elevated SHIV RNA in the Gut and a High Abundance of Intact SHIV DNA in Naive CD4(+) T Cells
por: Obregon-Perko, Veronica, et al.
Publicado: (2020)

In memory of a Legend: Dr. Shiv Shankar Gupta
por: Chandra, Dinesh
Publicado: (2013)

SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
por: Martin, Malcolm A
Publicado: (2013)

New SHIVs and Improved Design Strategy for Modeling HIV-1 Transmission, Immunopathogenesis, Prevention, and Cure
por: Li, Hui, et al.
Publicado: (2021)

Passive immunization with polyclonal anti-SHIV IgG: partial protection or increased acquisition of heterologous tier 2 SHIV – depending on IgG dose
por: Sholukh, AM, et al.
Publicado: (2012)

Passive immunization of macaques with polyclonal anti-SHIV IgG against a heterologous tier 2 SHIV: outcome depends on IgG dose
por: Sholukh, Anton M, et al.
Publicado: (2014)

Cooperation Between Systemic and Mucosal Antibodies Induced by Virosomal Vaccines Targeting HIV-1 Env: Protection of Indian Rhesus Macaques Against Low-Dose Intravaginal SHIV Challenges
por: Lakhashe, Samir K., et al.
Publicado: (2022)

Longitudinal analysis of the lung microbiota of cynomolgous macaques during long-term SHIV infection
por: Morris, Alison, et al.
Publicado: (2016)

Vaccination-Induced Noncytolytic Effects in the Acute Phase of SHIV Infection
por: Petravic, Janka, et al.
Publicado: (2010)

Systemic and Intestinal Viral Reservoirs in CD4+ T Cell Subsets in Primary SIV Infection
por: Wang, Xiaolei, et al.
Publicado: (2021)

Heterogeneous antiretroviral drug distribution and HIV/SHIV detection in the gut of three species
por: Thompson, Corbin G., et al.
Publicado: (2019)

Rhesus macaques show increased resistance to repeated SHIV intrarectal exposure following a heterologous regimen of rVSV vector vaccine expressing HIV antigen
por: Jelinski, Joseph, et al.
Publicado: (2023)

OA021-02. Replicating measles-SHIV vaccine induces long term preservation of central memory CD4 cells in the gut of vaccinated macaques challenged with SHIV
por: Tangy, F, et al.
Publicado: (2009)

Single dose topical inserts containing tenofovir alafenamide fumarate and elvitegravir provide pre- and post-exposure protection against vaginal SHIV infection in macaques
por: Dobard, Charles W., et al.
Publicado: (2022)

PD-1(HIGH) Follicular CD4 T Helper Cell Subsets Residing in Lymph Node Germinal Centers Correlate with B Cell Maturation and IgG Production in Rhesus Macaques
por: Xu, Huanbin, et al.
Publicado: (2014)

Immunopathogenesis in HIV-associated pediatric tuberculosis
por: Xu, Huanbin, et al.
Publicado: (2022)

HIV interactions and the perils of epithelial thinning in the female reproductive tract
por: Carias, A, et al.
Publicado: (2012)

Mucosal transmissibility, disease induction and coreceptor switching of R5 SHIV(SF162P3N) molecular clones in rhesus macaques
por: Ren, Wuze, et al.
Publicado: (2013)

Antibody mediated protection of immunized macaques against pathogenic SHIV challenge
por: Srivastava, Indresh K, et al.
Publicado: (2006)

Limited Effectiveness of Psoralen- and Ultraviolet-Inactivated Vaccinia Virus on SHIV Infection
por: Glenn, L. Lee
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_4bornsksum68r09gme9k1s7cvk